Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Bifidobacterium longum & Irritable Bowel Syndrome (IBS)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

NCT02213172 - 14PIHL - Bifidobacterium longum R0175 vs Lacticaseibacillus paracasei HA-196 & Irritable Bowel Syndrome (IBS)

This randomized, double-blind, placebo-controlled clinical phase II trial revealed that Bifidobacterium longum R0175 is capable of reducing the intensity of gastrointestinal symptoms and enhancing the psychological well-being of people with certain subtypes of irritable bowel syndrome (1).

(1) Lewis et al. 2020 Nutrients 12: 1159

Eﬃcacy of Lactobacillus paracasei HA-196 and Biﬁdobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study
Lewis et al. 2020 Nutrients 12: 1159

7/1/2026